22 Mar 2017

EpiPen recall

0 Comment

Dear Families,

 

Recall of EpiPen 300 – 20 March 2017

 

All EpiPens with an April 2017 expiry date are being recalled because of a possible defect that may result in difficulty activating the device in an emergency.

 

This recall is being conducted by Alphapharm in consultation with the Australian Therapeutic Goods Administration(TGA).

 

Alphapharm Initiates Recall of EpiPen® Auto-Injector in Australia

 

EpiPen® 300 microgram (?g) Adrenaline Injection Syringe Auto-Injector Batches 5FA665, 5FA6651, 5FA6652, 5FA6653

 

Alphapharm Pty Ltd, following consultation with the Therapeutic Goods Administration, is recalling the following batches of EpiPen® 300 microgram (?g) Adrenaline Injection Syringe Auto-Injectors due to the potential that these devices may contain a defective part that may result in the device failing to activate or requiring increased force to activate.

 

Batch number

 

Expiry

 

5FA665

 

Apr 17

 

5FA6651

 

Apr 17

 

5FA6652

 

Apr 17

 

5FA6653

 

Apr 17

 

Two reports world-wide have been confirmed of the device failing to activate in a batch of about 80,000 devices.

 

EpiPen® Auto-Injector is used for the treatment of allergic emergencies (anaphylaxis). The failure of the auto-injector to activate may result in patients not receiving the required dose of adrenaline resulting in the worsening of symptoms of anaphylaxis or anaphylactic reactions, which could be life threatening.

 

The recalled product was manufactured by Meridian Medical Technologies in St. Louis Missouri, USA.

 

Alphapharm is undertaking this recall as a precautionary measure and has patient safety as its first priority.

 

Instructions to consumers who have an EpiPen® Auto-Injector:

 

  1. Check if you have a 300 ?g EpiPen® (yellow carton and label) and if you do, check the batch number and expiry. The batch number and expiry can be found on the label of the pen or on the end of the carton.

 

  1. If your EpiPen® 300?g has the following batch numbers 5FA665, 5FA6651, 5FA6652 or 5FA6653 and an expiry of Apr 17, you need to replace it with a new one as soon as possible by returning to your pharmacist.

 

  1. Your pharmacist will replace the EpiPen® 300?g from the affected batch with an EpiPen® 300?g from a different batch FREE OF CHARGE.

 

  1. You must keep your current EpiPen® until you get a replacement and use it if required.

 

At this time, EpiPen® Jr 150?g Adrenaline Injection Syringe Auto-Injectors and all other batches of EpiPen® 300?g Adrenaline Injection Syringe Auto-Injectors are unaffected and are not subject to this recall.

 

Regards,

James Shore

Director | Sylvania Heights BASC

9522 7595 | www.sylvaniaheightsbasc.com.au

[top]